Qiagen N V (QGEN) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Qiagen N v   (NYSE: QGEN)


Qiagen N V's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Qiagen N V's ROI in the fourth quarter of 2025?
Qiagen N v achieved a return on average invested assets (ROI) of 8.38 % in its fourth quarter of 2025, this is above QGEN's average return on investment of 4.09%.
Qiagen N V s investments during the 12 months ending in the fourth quarter of 2025 are valued at $5 billion

ROI has improved compared to 1.57% in the third quarter of 2025, due to net income growth.

Within the Healthcare sector 125 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Dec 31 2025 quarter, so far to 905, from total ROI ranking in the third quarter of 2025 at 1916.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM 2.55 % 5.48 % 3.27 % 1.04 % -1.21 %
Y / Y Net Income Change TTM 408.28 % -75.51 % -75.51 % -75.51 % -75.51 %
Investment (TTM) in Millions 3,975 5,433 5,433 5,433 5,053
Return On Investment (TTM) 8.38 % 1.57 % 1.61 % 1.65 % 1.69 %
QGEN's Overall Ranking # 905 # 1916 # # #
Seq. Investment Change TTM -5.05 % 2.53 % 2.6 % 2.67 % -2.33 %
Seq. Net Income Change TTM 408.28 % 0 % 0 % 0 % -75.51 %
Net Income (TTM) in Millions 425 84 84 84 84

QGEN Company Profile >> Back to QGEN Roi Comparisons >> See Annual QGEN Return On Investment



Return On Investment QGEN's Ranking
Within: No.
Industry # 20
Sector # 126
Overall # 905

Return On Investment Statistics
High Average Low
10.69 %
4.09 %
-0.89 %
(Dec 31 2025)   (Dec 31 2019)







Financial Statements
Qiagen N V's IV. Quarter Investments $ 3,975 Millions QGEN's Balance sheet
Qiagen N V's IV. Quarter Income $ 425 Millions Quarterly QGEN's Income Statement
QGEN's Income by Division See QGEN's Income by Division


QGEN Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 3,975 5,053 5,526 5,590 5,551
Y / Y Investment Growth -21.33 % -8.55 % -1.14 % 0.7 % 5.72 %
Net Income in Millions 425 84 341 423 513
Y / Y Net Income Growth 408.28 % -75.51 % -19.35 % -17.44 % 42.71 %
Annual Return On Investment 10.69 % 1.65 % 6.18 % 7.57 % 9.23 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 10.69 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
QGEN's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for QGEN's Competitors
Subscribers only: Roi for Qiagen N V's Suppliers
Subscribers only: Return On Investment for QGEN's Customers

Other Ratios
QGEN's Roa QGEN's Inventory Turnover Ratio QGEN's Growth Rates QGEN's Dividend Statistics
QGEN's Profitability Ratios QGEN's Asset Turnover Ratio QGEN's Dividend Growth
QGEN's Roe QGEN's Valuation Ratios QGEN's Financial Strength Ratios QGEN's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI
Iradimed Corporation  22.97 %
Innoviva Inc   22.62 %
Illumina Inc   22.37 %
Transmedics Group Inc   21.99 %
Zoetis Inc   21.25 %
Pro dex Inc   21.04 %
Dexcom Inc   20.78 %
Electromed Inc   20.50 %
Resmed Inc   20.35 %
Merck and Co Inc   20.17 %
Astrazeneca Plc  19.67 %
Vertex Pharmaceuticals Inc  19.48 %
Inspire Medical Systems inc   19.34 %
Mimedx Group Inc   19.27 %
Gilead Sciences Inc   19.26 %
United Therapeutics Corporation  18.71 %
Krystal Biotech Inc   18.51 %
Agilent Technologies inc   18.50 %
Chemed Corporation  18.05 %
Hca Healthcare Inc   17.95 %
Sbc Medical Group Holdings Incorporated  17.85 %
Lifevantage Corp  17.77 %
Embecta Corp   17.69 %
Waters Corporation  17.39 %
Spero Therapeutics Inc   16.92 %
Johnson and Johnson  16.85 %
Halozyme Therapeutics Inc   16.47 %
Intuitive Surgical Inc   15.81 %
Black Diamond Therapeutics Inc   15.47 %
Strata Critical Medical Inc   15.07 %

Date modified: 2026-07-07T12:43:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.